Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,922,083 papers from all fields of science
Search
Sign In
Create Free Account
rivastigmine 1.5 MG Oral Capsule
Known as:
rivastigmine 1.5 MG (as rivastigmine tartrate 2.4 MG) Oral Capsule
, RIVASTIGMINE TARTRATE 1.5 mg ORAL CAPSULE [Rivastigmine Tartrate]
, RIVASTIGMINE TARTRATE 1.5MG CAP,UD
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
28 relations
1-Butanol
Alzheimer's Disease
Ammonia
Carbamates
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
[Oral galantamine versus rivastigmine transdermal patch: a descriptive study at a memory clinic in The Netherlands].
C. J. Wouters
,
L. Dautzenberg
,
A. Thissen
,
P. L. Dautzenberg
Tijdschrift voor Gerontologie en Geriatrie
2010
Corpus ID: 25145705
OBJECTIVES Since January 2008 in The Netherlands, two cholinesterase inhibitors, oral galantamine and rivastigmine transdermal…
Expand
2008
2008
No significant effects of single intravenous, single oral and subchronic oral administration of acetylcholinesterase inhibitors on striatal [123I]FP-CIT binding in rats
R. Knol
,
K. Bruin
,
B. Eck-Smit
,
Jan Booij
European Journal of Nuclear Medicine and…
2008
Corpus ID: 21529971
Purpose[123I]FP-CIT SPECT is a valuable diagnostic tool to discriminate Lewy body dementia from Alzheimer’s dementia. To date…
Expand
2001
2001
Evaluation of cholinergic treatment in demented patients by P300 evoked related potentials.
A. Werber
,
C. Klein
,
J. Rabey
Neurologia i Neurochirurgia Polska
2001
Corpus ID: 25018083
Centrally acting cholinesterase inhibitors (ChEls) improve cognitive functions in Alzheimer's disease (AD) and other forms of…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE